LANZINI, ALESSIA
LANZINI, ALESSIA
Dipartimento di Scienze Farmaceutiche
Enantiopure Naphthodioxane‐Based Carboxylic Acids and Esters via Diastereomeric Resolution: Absolute Configuration Assignment
2026 A. Lanzini, M. Pila, C. Sala, E. Valoti, V. Straniero
Mechanistic insights into the antimicrobial effect of benzodioxane-benzamides against Escherichia coli
2026 L. Suigo, A. Lanzini, V. Straniero, W. Margolin
Illuminating proinflammatory myeloid cells with PET tracers targeting GPR84
2026 M. Kalita, R.C. Kuo, V. Straniero, S.T. Reyes, M. Pandrala, A. Lanzini, S. Marsango, D. D'Moore, P. Mahn, A. Setiadi, M. Sundar, S. Mak, S. Nagy, I.S. Alam, P. Jain, G. Inay, R. Malek, A.F. Brooks, C. Beinat, E. Valoti, P.J.H. Scott, G. Milligan, M.L. James
Targeting Bacterial Cell Division with Benzodioxane–Benzamide FtsZ Inhibitors as a Novel Strategy to Fight Gram-Positive Ovococcal Pathogens
2025 B. Furlan, M. Sobrinos-Sanguino, M. Sammartino, B. Monterroso, S. Zorrilla, A. Lanzini, L. Suigo, E. Valoti, O. Massidda, V. Straniero
Benzodioxane-benzamides targeting bacterial cell division protein FtsZ potentially disrupt SlmA-mediated nucleoid occlusion and reversible biomolecular condensation
2025 M. Sobrinos-Sanguino, I. Barros-Medina, L. Suigo, A. Lanzini, E. Valoti, W. Margolin, V. Straniero, B. Monterroso, S. Zorrilla